Form D · Other Technology
Imbio LLC
Minneapolis, MN · CIK 0001578267
Offering snapshot reported Sep 3, 2015 · SEC filing
- Reported sold
- $1.08M Offering amount: $2.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 31, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 3, 2015 | Initial | $1,077,695 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-246970
Source: Form D, filed Sep 3, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Danny J. Cunagin | Director, Executive |
| David Hannes | Executive |
| Troy D. Kopischke | Director, Executive |
| Cynthia Maier | Director, Executive |
| Alnawaz Rehemtulla, M.D. | Director |
| Mark Sylvester | Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
227 Colfax Avenue North Suite 144
Minneapolis, MN, 55405
Minneapolis, MN, 55405